TeraWulf’s Aggressive HPC and AI Push Wins Citi Backing
Wall Street consensus is Strong Buy at $36.34, implying 40% upside as the company pivots aggressively into AI and HPC infrastructure.
NOTRELOAD AI
SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming
Despite the massive demand boost, analysts remain cautious, citing the company’s $4.9 billion net loss last year and concerns over valuation.
Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised
The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.
Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle
Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.
BTIG Bullish on Robinhood: Launches Coverage with $125 Target, Citing Long-Term Compounding Power
BTIG is bullish on Robinhood, seeing strong growth, young users, rising trading activity, and a $125 price target.
Moderna Shares Surge as Oncology Pipeline Ignites Investor Optimism
Piper Sandler raised its price target on Moderna from $69 to $77, maintaining an Overweight rating. Strong momentum in the oncology pipeline is fueling the rally.